Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,303 | 1,012 | 96.6% |
| Education | $508.76 | 14 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,816 | 126 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,434 | 70 | $0 (2024) |
| PFIZER INC. | $1,315 | 138 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,092 | 82 | $0 (2024) |
| Lilly USA, LLC | $968.69 | 76 | $0 (2024) |
| Astellas Pharma US Inc | $733.00 | 31 | $0 (2024) |
| Amgen Inc. | $726.31 | 53 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $661.54 | 33 | $0 (2024) |
| ABBVIE INC. | $655.59 | 60 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $643.95 | 48 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,547 | 138 | AstraZeneca Pharmaceuticals LP ($354.75) |
| 2023 | $2,193 | 133 | AbbVie Inc. ($274.03) |
| 2022 | $224.01 | 14 | Novartis Pharmaceuticals Corporation ($51.22) |
| 2021 | $722.86 | 44 | Novo Nordisk Inc ($129.56) |
| 2020 | $1,547 | 104 | AstraZeneca Pharmaceuticals LP ($265.72) |
| 2019 | $2,616 | 206 | PFIZER INC. ($369.25) |
| 2018 | $2,634 | 192 | Novo Nordisk Inc ($456.81) |
| 2017 | $2,328 | 195 | Novo Nordisk Inc ($362.60) |
All Payment Transactions
1,026 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Diabetes Care | ||||||
| 12/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.64 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $119.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Endocrinology | ||||||
| 12/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $6.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: VACCINE | ||||||
| 12/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Cardio-renal | ||||||
| 11/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: VACCINES | ||||||
| 11/25/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: PAIN | ||||||
| 11/21/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Bone Health | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $7.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $6.44 | General |
| Category: PAIN | ||||||
| 11/14/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: Endocrinology | ||||||
| 11/14/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $5.89 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: VACCINE | ||||||
| 11/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/04/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $9.64 | General |
| Category: PAIN | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.69 | General |
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Education | In-kind items and services | $8.45 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 415 | 848 | $235,571 | $55,897 |
| 2022 | 6 | 414 | 823 | $209,818 | $49,126 |
| 2021 | 8 | 562 | 1,040 | $294,510 | $74,162 |
| 2020 | 9 | 646 | 1,169 | $329,916 | $75,691 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 254 | 575 | $100,789 | $36,646 | 36.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 46 | 133 | $59,397 | $8,383 | 14.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 37 | 44 | $42,851 | $4,572 | 10.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 28 | 32 | $23,438 | $2,860 | 12.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 53 | $6,036 | $2,481 | 41.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,060 | $956.07 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 250 | 508 | $84,341 | $30,821 | 36.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 42 | 138 | $58,026 | $7,630 | 13.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 27 | 34 | $31,029 | $3,484 | 11.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 33 | 42 | $19,250 | $3,413 | 17.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 71 | $8,034 | $2,878 | 35.8% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 14 | 30 | $9,138 | $900.41 | 9.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 278 | 547 | $86,308 | $41,552 | 48.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 90 | 251 | $99,654 | $13,952 | 14.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 59 | 70 | $60,510 | $7,317 | 12.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 45 | 56 | $21,356 | $4,587 | 21.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 53 | 66 | $6,758 | $3,776 | 55.9% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 12 | 12 | $7,766 | $1,272 | 16.4% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 13 | 26 | $7,544 | $1,026 | 13.6% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 12 | 12 | $4,614 | $679.08 | 14.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 261 | 488 | $73,100 | $31,745 | 43.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 123 | 329 | $122,774 | $18,886 | 15.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 65 | 76 | $62,012 | $8,198 | 13.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 69 | 80 | $28,684 | $6,606 | 23.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 66 | 94 | $9,400 | $4,389 | 46.7% |
About Dr. Angel Blazquez, M.D
Dr. Angel Blazquez, M.D is a Family Medicine healthcare provider based in Sterling, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245280155.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Angel Blazquez, M.D has received a total of $14,812 in payments from pharmaceutical and medical device companies, with $2,547 received in 2024. These payments were reported across 1,026 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($14,303).
As a Medicare-enrolled provider, Blazquez has provided services to 2,037 Medicare beneficiaries, totaling 3,880 services with total Medicare billing of $254,875. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Sterling, IL
- Active Since 05/11/2006
- Last Updated 07/06/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1245280155
Products in Payments
- Ozempic (Drug) $692.51
- FARXIGA (Drug) $616.01
- TRULICITY (Drug) $596.60
- JANUVIA (Drug) $583.84
- Victoza (Drug) $541.37
- CHANTIX (Drug) $484.46
- ENTRESTO (Drug) $456.29
- Korlym (Drug) $409.44
- Kerendia (Drug) $408.64
- ELIQUIS (Drug) $355.58
- SYMBICORT (Drug) $353.61
- VRAYLAR (Drug) $299.08
- UBRELVY (Drug) $292.36
- Tresiba (Drug) $291.56
- SPIRIVA RESPIMAT (Drug) $256.06
- NURTEC ODT (Drug) $233.96
- Aimovig (Biological) $226.19
- LEQVIO (Drug) $205.25
- Minimed 670G System (Device) $195.12
- ANORO (Drug) $193.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Sterling
Peter Toth, M.d, M.D
Family Medicine — Payments: $2.2M
Dr. Charles Gerk, M.d, M.D
Family Medicine — Payments: $37,719
Svetlana Nakatis, M.d, M.D
Family Medicine — Payments: $7,951
Ralph Leon, Md, MD
Family Medicine — Payments: $7,465
Ricardo Ferreira Lopez, Md, MD
Family Medicine — Payments: $6,458
Phong Dang, M.d, M.D
Family Medicine — Payments: $4,674